Search Results 821-830 of 18075 for monoclonal antibody
Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Acalabrutinib may stop the growth of cancer ...
Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...
Participation eligibility · Must be at least 4 weeks (for FL) or 2 weeks (for DLBCL) since prior cytotoxic, biologic, monoclonal antibody, or investigational ...
Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
The first calcitonin gene-related peptide monoclonal antibody to prevent migraine was approved in 2018. Today, four drugs have been approved: Eptinezumab ...
Pembrolizumab is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...
... antibody-drug conjugate (ADC) for the treatment of relapsed or ... Monoclonal antibodies, such as isatuximab, may interfere with the ability of ...
Monoclonal antibodies, such as nivolumab, may interfere with the ability of tumor cells to grow and spread. Giving nivolumab before nephrectomy may make the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.